Fluorophotometric Determination of Riboflavin Concentrations in a Human Artificial Anterior Chamber Model.

Fluorotron Master FM-2 cross-linking fluorophotometry riboflavin

Journal

Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 06 05 2019
accepted: 01 09 2019
entrez: 19 11 2019
pubmed: 19 11 2019
medline: 19 11 2019
Statut: epublish

Résumé

Corneal cross-linking (CXL) requires an adequate corneal riboflavin impregnation, which is clinically assessed by verification of a riboflavin "flare" in the anterior chamber. We set out to replace this subjective assessment with an objective measurement method and evaluated fluorophotometry as an apparatus-based technique for riboflavin detection in the anterior chamber. In an artificial anterior chamber model using human corneas and a modified Fluorotron fluorophotometer, we determined the detection limits of riboflavin concentrations across native corneas by comparison measurements of the same concentrations in glass cuvettes. Subsequently, standard CXL procedures with corneal application of riboflavin were simulated and the proportions of riboflavin entering the anterior chamber were measured fluorophotometrically. The measurement results of the riboflavin dilution series in the artificial anterior chamber showed a very high concordance with the results obtained in a glass cuvette (Pitman test Fluorophotometry is able to measure riboflavin in an artificial anterior chamber across human corneas over a wide range of concentrations and it reliably detects the increasing riboflavin signal in simulated CXL procedures. The replacement of the subjective riboflavin detection by a technically straightforward, objective detection method might increase patient safety and treatment efficiency in CXL.

Identifiants

pubmed: 31737431
doi: 10.1167/tvst.8.6.7
pii: TVST-19-1609
pmc: PMC6855370
doi:

Types de publication

Journal Article

Langues

eng

Pagination

7

Informations de copyright

Copyright 2019 The Authors.

Références

Invest Ophthalmol Vis Sci. 2015 Jul;56(8):5006-11
pubmed: 26230765
Invest Ophthalmol Vis Sci. 2016 Feb;57(2):476-83
pubmed: 26868750
Exp Eye Res. 1990 Aug;51(2):113-8
pubmed: 2387331
Graefes Arch Clin Exp Ophthalmol. 1985;222(4-5):223-4
pubmed: 3979848
Am J Ophthalmol. 2003 May;135(5):620-7
pubmed: 12719068
Cornea. 2007 May;26(4):385-9
pubmed: 17457183
Invest Ophthalmol Vis Sci. 2011 Sep 01;52(10):7038-45
pubmed: 21791594
Nat Methods. 2005 Dec;2(12):932-40
pubmed: 16299478
Graefes Arch Clin Exp Ophthalmol. 1985;222(4-5):209-11
pubmed: 3979845
Graefes Arch Clin Exp Ophthalmol. 1985;222(4-5):225-9
pubmed: 3979849
Invest Ophthalmol Vis Sci. 2014 Apr 17;55(4):2476-81
pubmed: 24644056
Eur J Ophthalmol. 2017 May 11;27(3):253-269
pubmed: 28009397
Br J Ophthalmol. 2002 Jun;86(6):616-9
pubmed: 12034680
Int J Pharm. 2013 Jan 20;440(2):148-53
pubmed: 23046664
Am J Ophthalmol. 2014 Mar;157(3):623-30.e1
pubmed: 24321474
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3844-52
pubmed: 27447085
Br J Ophthalmol. 1990 Jul;74(7):431-2
pubmed: 2198933

Auteurs

Katja C Iselin (KC)

Dept of Ophthalmology, Lucerne Cantonal Hospital, Lucerne, Switzerland.

Michael A Thiel (MA)

Dept of Ophthalmology, Lucerne Cantonal Hospital, Lucerne, Switzerland.

Lucas M Bachmann (LM)

Medignition Healthcare Innovations, Zurich, Switzerland.

Philipp B Baenninger (PB)

Dept of Ophthalmology, Lucerne Cantonal Hospital, Lucerne, Switzerland.

Claude Kaufmann (C)

Dept of Ophthalmology, Lucerne Cantonal Hospital, Lucerne, Switzerland.

Classifications MeSH